NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Cited by (862)

Items 301–400 of 862

1. Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center
   Chunjui Chen, Hao Xu, Kun Song, Yi Zhang, Junyan Zhang, Yang Wang, Xiaofang Sheng, Lingchao Chen, Zhiyong Qin · 2022 · Journal of Clinical Medicine
2. Cancer of the Central Nervous System
   Jay F. Dorsey, Ryan D. Salinas, Mai T. Dang, Michelle Alonso‐Basanta, Kevin D Judy, Amit M. Maity, Robert A. Lustig, John Y. K. Lee, Peter C. Phillips∥, Amy A. Pruitt · 2020 · Elsevier eBooks
3. Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data
   Dimitra Smerdi, Myrto K. Moutafi, Ioannis Kotsantis, Lampis C. Stavrinou, Amanda K. Psyrri · 2024 · Life
4. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience
   Yun Guan, Ji Xiong, Mingyuan Pan, Wenyin Shi, Jing Li, Huaguang Zhu, Xiu Gong, Chao Li, Guanghai Mei, Xiaoxia Liu et al. · 2021 · BMC Cancer
5. Re-irradiation for high-grade gliomas: Has anything changed?
   Sonia García Cabezas, Eleonor Rivin del Campo, J. Solivera Vela, Amalia Palacios · 2021 · World Journal of Clinical Oncology
6. Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study
   Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori · 2023 · Japanese Journal of Clinical Oncology
7. Current Development of Glioblastoma Therapeutic Agents
   Zilai Wang, Norton P. Peet, Pin Zhang, Yuwei Jiang, Lijun Rong · 2021 · Molecular Cancer Therapeutics
8. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI
   Edit Bosnyák, David Olayinka. Kamson, Natasha L. Robinette, Geoffrey R. Barger, Sandeep Mittal, Csaba Juhász · 2015 · Journal of Neuro-Oncology
9. Inhibition of brain tumor cell proliferation by alternating electric fields
   Hyesun Jeong, Jiwon Sung, Seung-Ick Oh, Seong Hoon Jeong, Eui Kwan Koh, Sunghoi Hong, Myonggeun Yoon · 2014 · Applied Physics Letters
10. Medical Management of High-Grade Astrocytoma: Current and Emerging Therapies
    Derek Richard Johnson, Evanthia Galanis · 2014 · Seminars in Oncology
11. A systematic review of tumor treating fields therapy for high-grade gliomas
    Pavan P. Shah, Taija White, Adham M. Khalafallah, Carlos Guillermo Romo, Carrie L Price, Debraj Raj Mukherjee · 2020 · Journal of Neuro-Oncology
12. Clinical Efficacy of Tumor Treating Fields for Newly Diagnosed Glioblastoma
    Yang Liu, Myla S. Strawderman, Kwanza Warren, Margie Richardson, Jennifer N Serventi, Nimish A. Mohile, Michael T. Milano, Kevin A. Walter · 2020 · Anticancer Research
13. Cold Plasma Discharge Tube Enhances Antitumoral Efficacy of Temozolomide
    Xiaoliang Yao, Dayun Yan, Li Lin, Jonathan H. Sherman, Katherine B. Peters, Stephen Thomas Keir, Michael Keidar · 2022 · ACS Applied Bio Materials
14. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults
    Isabelle M. Germano, Mateo Ziu, Patrick Yung Wen, David Ryan Ormond, Jeffrey J. Olson · 2022 · Journal of Neuro-Oncology
15. Effectiveness and safety of tumor-treating fields therapy for glioblastoma: A single-center study in a Chinese cohort
    Lei She, Xuan Gong, Lin Su, Chao Liu · 2023 · Frontiers in Neurology
16. Treatment advances in high-grade gliomas
    Xi Chen, Yi Cui, Liqun Zou · 2024 · Frontiers in Oncology
17. Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme
    Fabio Raman, Elizabeth Y. Scribner, Olivier Saut, Cornelia Wenger, Thierry Colin, Hassan M. Fathallah‐Shaykh · 2016 · PLoS ONE
18. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells
    Ryogo Kikuchi, Oltea Sampetrean, Hideyuki Saya, Kazunari Yoshida, Masahiro Toda · 2017 · Journal of Neuro-Oncology
19. Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality
    Eric T. Wong, Edwin Lok, Kenneth D. Swanson · 2018 · Progress in neurological surgery
20. Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
    Andrea R. Di Sebastiano, Andrew M. Deweyert, Simon M. Benoit, Erin Iredale, Hu Xu, Cleusa De Oliveira, Eugene Wong, Susanne Schmid, Matthew O. Hebb · 2018 · Scientific Reports
21. Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma
    Antonio Dono, Mark J. Amsbaugh, Magda Martir, Richard H. Smilie, Roy Riascos, Jay‐Jiguang Zhu, Sigmund H. Hsu, Dong Kim, Nitin Tandon, Leomar Y. Ballester et al. · 2021 · Journal of Neuro-Oncology
22. Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors
    Joshua Branter, Maria de los Angeles Estevez-Cebrero, Mohammed Diksin, Michaela Griffin, Marcos Castellanos‐Uribe, Sean Tobias May, Ruman Rahman, Richard Guy Grundy, Surajit Basu, Stuart James Smith · 2022 · International Journal of Molecular Sciences
23. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline
    Nimish A. Mohile, Hans J. Messersmith, Na Tosha Gatson, Andreas Felix Hottinger, Andrew B. Lassman, Jordan Morton, Douglas Edward Ney, Phioanh Leia Nghiemphu, Adriana Olar, Jeffrey J. Olson et al. · 2021 · Neuro-Oncology
24. Tumor Treating Fields (TTFields) therapy vs physicians’ choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19)
    Jay‐Jiguang Zhu, Samuel Aaron Goldlust, Lawrence Richard Kleinberg, Jérôme Honnorat, Nancy Ann Oberheim Bush, Zvi Ram · 2022 · Discover Oncology
25. How Treatment Monitoring Is Influencing Treatment Decisions in Glioblastomas
    Martha R. Neagu, Raymond Y. Huang, David A. Reardon, Patrick Yung Wen · 2015 · Current Treatment Options in Neurology
26. Brain metastasis
    Matthias Preusser, Anna Sophie Berghoff, Dirk Schadendorf, NU Lin, Roger Stupp · 2012 · Current Opinion in Neurology
27. Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
    George Ansstas, David Dinh Tran · 2016 · Case Reports in Neurology
28. Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction
    Supriya Mallick, Ajeet Kumar Gandhi, Goura Kishor Rath · 2015 · Indian Journal of Medical and Paediatric Oncology
29. Optimization of tumor treating fields using singular value decomposition and minimization of field anisotropy
    Anders Rosendal Korshoej, Jens Chr. Sørensen, Gorm von Öettingen, Frantz Rom Poulsen, Axel Thielscher · 2019 · Physics in Medicine and Biology
30. MiR-374b targets GATA3 to promote progression and development of glioblastoma via regulating SEMA3B
    Jun Gao, Shuoqiu Bai, Yongzhao Wang, S. Zhao, Zhiping He, R. Wang · 2019 · Neoplasma
31. A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States
    Andrew David Norden, Beata Korytowsky, Min Su You, T. Kim Le, Homa B. Dastani, Sarah N. Bobiak, Prianka Singh · 2019 · Journal of Managed Care & Specialty Pharmacy
32. Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation
    Il Han Kim · 2019 · Radiation Oncology Journal
33. Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
    Jana Portnow, Behnam Badie, M. Suzette Blanchard, Julie Kilpatrick, Revathiswari Tirughana, Marianne Z. Metz, Shu Mi, Vivi Tran, Julie Ann Ressler, Massimo D’Apuzzo et al. · 2020 · Cancer Gene Therapy
34. Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas – a planning study
    Christoph Straube, Markus Oechsner, S. Kampfer, Sophia Scharl, Friederike Schmidt‐Graf, Jan J. Wilkens, Stephanie Elisabeth Combs · 2018 · Radiation Oncology
35. Tumor treating fields in pediatric high-grade glioma
    Adam L. Green, Jean M. Mulcahy Levy, Rajeev Vibhakar, Molly S. Hemenway, Jennifer R. Madden, Nicholas K. Foreman, Kathleen McCarthy O'Toole Dorris · 2017 · Child s Nervous System
36. Approved Treatments for Patients with Recurrent High-grade Gliomas
    Caroline Kane Laub, Jennifer Stefanik, Lisa M. Doherty · 2018 · Seminars in Oncology Nursing
37. Current clinical management of patients with glioblastoma
    Stephen R. Lowe, Krishna Bhat, Adriana Olar · 2019 · Cancer Reports
38. Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial
    Nikola Mikic, Frantz Rom Poulsen, Kristina B Kristoffersen, R. J. Laursen, Trine Lignell Guldberg, Jane Skjøth‐Rasmussen, Eric T. Wong, S. Møller, Rikke Hedegaard Dahlrot, Jens Christian Hedemann Sørensen et al. · 2021 · BMC Cancer
39. The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV
    Aleksandrs Krigers, Daniel Pinggera, Matthias Demetz, Lisa-Marie Kornberger, Johannes Kerschbaumer, Claudius Thomé, Christian Franz Freyschlag · 2022 · Frontiers in Neurology
40. Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
    Ignace B. Vergote, Teresa Mercade Macarulla, Fred R. Hirsch, Carsten Hagemann, David Scott Miller · 2023 · Cancers
41. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme
    Mekala Janaki Ramaiah, Kowsalya Adusumilli, Sahiti Chamarthy, Hari Sai Ram Angirekula · 2023 · Metabolic Brain Disease
42. Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma
    J L Chen, Yuyang Liu, Jinxin Lan, Hongyu Liu, Qingyun Tang, Ze Li, Xiaoguang Qiu, Wentao Hu, Jiaxin Xie, Yaping Feng et al. · 2024 · CNS Neuroscience & Therapeutics
43. Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier
    Aadya Nayak, Neerada Meenakshi Warrier, Rachana Raman, Vijendra Prabhu, Praveen Kumar · 2024 · Journal of Drug Delivery Science and Technology
44. Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study
    Yung-Shin Sun · 2018 · Computational and Mathematical Methods in Medicine
45. Overview on current treatment standards in high-grade gliomas
    Alessia Pellerino, Federica Franchino, Riccardo Soffietti, Roberta Rudà · 2018 · The Quarterly Journal of Nuclear Medicine and Molecular Imaging
46. An early feasibility study of the Nativis Voyager ® device in patients with recurrent glioblastoma: first cohort in US
    Charles Cobbs, Edward Francis McClay, J. Paul Duic, Burt Nabors, Donna Morgan Murray, Santosh Kesari · 2018 · CNS Oncology
47. Patient Reported Outcome (PRO) Among High-Grade Glioma Patients Receiving TTFields Treatment: A Two Center Observational Study
    Julia Onken, Ute Goerling, Marcel Heinrich, Stephanie Pleissner, Dietmar Krex, Peter Vajkoczy, Martin Misch · 2019 · Frontiers in Neurology
48. A Correlation Between Electric Fields That Target the Cell Membrane Potential and Dividing HeLa Cancer Cell Growth Inhibition
    Xing Li, Fan Yang, Boris Rubinsky · 2020 · IEEE Transactions on Biomedical Engineering
49. Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers
    Travis H. Jones, Jonathan W. Song, Laith I. Abushahin · 2021 · Translational Oncology
50. Temperature and Impedance Variations During Tumor Treating Fields (TTFields) Treatment
    Nichal Gentilal, Eyal Abend, Ariel Naveh, Tal Marciano, Igal Balin, Yevgeniy Telepinsky, Pedro Cavaleiro Miranda · 2022 · Frontiers in Human Neuroscience
51. Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions
    Silvia Mara Baez Rodriguez, Ligia Gabriela Tătăranu, Amira Kamel, Șerban Turliuc, Radu Eugen Rizea, Anica Dricu · 2024 · International Journal of Molecular Sciences
52. Metastatic brain tumors: from development to cutting‐edge treatment
    Guilong Tanzhu, Liu Chen, Jiaoyang Ning, Wenxiang Xue, Ce Wang, Gang Xiao, Jie Yang, Rongrong Zhou · 2024 · MedComm
53. Assessment of early response to tumor-treating fields in newly diagnosed glioblastoma using physiologic and metabolic MRI: initial experience
    Suyash Mohan, Sanjeev Chawla, Sumei Wang, Gaurav Verma, Aaron D. Skolnik, Steven S. Brem, Katherine B. Peters, Harish Poptani · 2016 · CNS Oncology
54. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas
    Eric T. Wong, Joshua J. Timmons, Amy Callahan, Lauren O’Loughlin, Bridget Giarusso, David C. Alsop · 2016 · BMC Cancer
55. Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study
    Abdalla Aly, Prianka Singh, Beata Korytowsky, You‐Li Ling, Hrishikesh P. Kale, Homa B. Dastani, Marc F Botteman, Andrew David Norden · 2019 · Neuro-Oncology Practice
56. Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging
    Vikram S. Soni, Ted K. Yanagihara · 2019 · Cancer Imaging
57. Update on Brain Tumors: New Developments in Neuro‐oncologic Diagnosis and Treatment, and Impact on Rehabilitation Strategies
    Samman Shahpar, Priya V. Mhatre, Mark E. Huang · 2015 · PM&R
58. NovoTTF: where to go from here?
    Timothy Francis Cloughesy, Andrew B. Lassman · 2017 · Neuro-Oncology
59. Personalised, image-guided, noninvasive brain stimulation in gliomas: Rationale, challenges and opportunities
    Giulia Sprugnoli, Símone Rossi, Alexander Rotenberg, Álvaro Pascual‐Leone, Georges El Fakhri, Alexandra J. Golby, Emiliano Santarnecchi · 2021 · EBioMedicine
60. Current therapeutic options for glioblastoma and future perspectives
    Elisa Aquilanti, Patrick Yung Wen · 2022 · Expert Opinion on Pharmacotherapy
61. Analyzing the role of reoperation in recurrent glioblastoma: a 15-year retrospective study in a single institution
    Víctor González Jiménez, Marta Brell, José Fuster, Lesmes Moratinos, Daniel Alegre, Sofía López, Javier Ibáñez · 2022 · World Journal of Surgical Oncology
62. Novel therapeutic strategies in glioma targeting glutamatergic neurotransmission
    Ashwin Kumaria, Keyoumars Ashkan · 2023 · Brain Research
63. Comprehensive insights into glioblastoma multiforme: drug delivery challenges and multimodal treatment strategies
    Ashish Dhiman, Dhwani Rana, Derajram M. Benival, Kalpna Garkhal · 2024 · Therapeutic Delivery
64. Modelling Tumor Treating Fields for the treatment of lung-based tumors
    Zéev Bomzon, Noa Urman, Cornelia Wenger, Moshe Giladi, Uri Weinberg, Yoram Wasserman, Eilon David Kirson, Pedro Cavaleiro Miranda, Yoram Palti · 2015 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
65. Tumor treating fields in neuro-oncology: integration of alternating electric fields therapy into promising treatment strategies
    Tamar R. Berger, Eric T. Wong · 2020 · Chinese Clinical Oncology
66. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults
    Mateo Ziu, Sharad Goyal, Jeffrey J. Olson · 2021 · Journal of Neuro-Oncology
67. Synergistic Action of Gefitinib and GSK41364A Simultaneously Loaded in Ratiometrically-Engineered Polymeric Nanoparticles for Glioblastoma Multiforme
    Praveena Velpurisiva, Prakash Rai · 2019 · Journal of Clinical Medicine
68. Reduction of intratumoral brain perfusion by noninvasive transcranial electrical stimulation
    Giulia Sprugnoli, Lucia Monti, Laura Lippa, Francesco Neri, Lucia Mencarelli, Giulio Ruffini, Ricardo Salvador, G Oliveri, B. Batani, Davide Momi et al. · 2019 · Science Advances
69. Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas
    Prakirthi Yerram, Samantha Reiss, Lisa R. Modelevsky, Igor T. Gavrilovic, Thomas Joseph Kaley · 2019 · Journal of Neuro-Oncology
70. Skull modulated strategies to intensify tumor treating fields on brain tumor: a finite element study
    Xin Yang, Penghao Liu, Hao Xing, Xiaoyan Wen, Yu Wang, Chunhua Hu, Luming Li, Wenbin Ma · 2022 · Biomechanics and Modeling in Mechanobiology
71. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence
    Gbolahan Deji Olatunji, Nicholas Aderinto, Adefusi Temiloluwa Oluwakorede, Emmanuel Kokori, Olumide Damilola Akinmoju, Ismaila Ajayi Yusuf, Tobi Caleb Olusakin, Muhammad Ali Muzammil · 2023 · Medicine
72. Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011–2022
    Maciej M. Mrugała, Wenyin Shi, Fabio Iwomoto, Rimas Vincas Lukas, Joshua David Palmer, John H. Suh, Martin Glas · 2024 · Journal of Neuro-Oncology
73. Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date
    Olivier Louis Chinot · 2012 · Expert Review of Anticancer Therapy
74. First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: a case report
    Daniel O’Connell, Violet Shen, William G. Loudon, Daniela Annenelie Bota · 2016 · CNS Oncology
75. Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience
    Garry S. Ceccon, Lazaros Lazaridis, Gabriele Stoffels, Marion Rapp, Manuel Weber, Tobias Blau, Philipp Lohmann, Sied Kebir, Ken Herrmann, Gereon R. Fink et al. · 2018 · European Journal of Nuclear Medicine and Molecular Imaging
76. Tumor-Treating Fields Therapy for Pediatric Brain Tumors
    Atsushi Makimoto, Ryo Nishikawa, Keita Terashima, Jun Kurihara, Hiroyuki Fujisaki, Satoshi Ihara, Yoshihiko Morikawa, Yuki Yuza · 2021 · Neurology International
77. Delayed response and survival from NovoTTF-100A in recurrent GBM
    John Lee Villano, Leena E. Williams, Karriem S. Watson, Nandini Ignatius, Marquess T. Wilson, Tibor Vályi-Nagy, Edward A. Michals, Herbert H. Engelhard · 2013 · Medical Oncology
78. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme
    Richard Martin Bambury, Patrick Glyn Morris · 2014 · Expert Review of Anticancer Therapy
79. Immune Cell Interplay in the Fight Against GBM
    Nico Vallieri, Angeliki Datsi · 2025 · Cancers
80. Updates in the Management of Recurrent Glioblastoma Multiforme
    Hanuman Prasad Prajapati, Ahmad Ansari · 2022 · Journal of Neurological Surgery Part A Central European Neurosurgery
81. Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions
    Koustav Pal, Rahul A. Sheth · 2022 · Cancers
82. Modeling of intracranial tumor treating fields for the treatment of complex high-grade gliomas
    David J. Segar, Joshua D. Bernstock, Omar M. Arnaout, Wenya Linda Bi, Gregory K. Friedman, Róbert Langer, Giovanni Traverso, Sumientra M. Rampersad · 2023 · Scientific Reports
83. Tumor-treating fields dosimetry in glioblastoma: Insights into treatment planning, optimization, and dose–response relationships
    Nikola Mikic, Nichal Gentilal, Fang Cao, Edwin Lok, Eric T. Wong, Matthew T. Ballo, Martin Glas, Pedro Cavaleiro Miranda, Axel Thielscher, Anders Rosendal Korshoej · 2024 · Neuro-Oncology Advances
84. Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target
    Roger Stupp, Michael Weller · 2014 · Neuro-Oncology
85. Tumor Treating Fields in Neuro-Oncological Practice
    Maciej M. Mrugała, Jacob Ruzevick, Piotr Złomańczuk, Rimas Vincas Lukas · 2017 · Current Oncology Reports
86. Localized targeted antiangiogenic drug delivery for glioblastoma
    Gregory D. Arnone, Abhiraj D. Bhimani, Tania M. Aguilar, Ankit Indravadan Mehta · 2018 · Journal of Neuro-Oncology
87. Effectiveness of a Fractionated Therapy Scheme in Tumor Treating Fields Therapy
    Yunhui Jo, Jiwon Sung, Hyesun Jeong, Sunghoi Hong, Youn Kyoung Jeong, Eun Ho Kim, Myonggeun Yoon · 2019 · Technology in Cancer Research & Treatment
88. Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma
    Lena Rosenlund, Eskil Degsell, Asgeir Store Jakola · 2019 · Patient Related Outcome Measures
89. Reirradiation of High-Grade Gliomas: A Retrospective Analysis of 198 Patients Based on the Charité Data Set
    David Kaul, Vera Linda Pudlitz, Dirk Böhmer, Peter Wust, Volker Budach, Arne Grün · 2020 · Advances in Radiation Oncology
90. Potential role of microRNAs as biomarkers in human glioblastoma: a mini systematic review from 2015 to 2020
    Manuela Rocha de Menezes, Maria Eduarda Azevêdo Acioli, Ana Carolina Lemos da Trindade, Suéllen Pedrosa da Silva, Raul Emídio de Lima, Vanessa Gabryelle da Silva Teixeira, Luydson Richardson Silva Vasconcelos · 2021 · Molecular Biology Reports
91. Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data
    Tuğçe Kütük, Haley R. Appel, Maria Carolina Avendano, Federico Albrecht, Paul Kaywin, Suyen Ramos, M. Suarez-Murias, Minesh P. Mehta, Rupesh R Kotecha · 2022 · Cancers
92. Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation
    Ted K. Yanagihara, Heva Jasmine Saadatmand, Tony J. C. Wang · 2016 · Journal of Neuro-Oncology
93. Estimating the Intensity and Anisotropy of Tumor Treating Fields Jsing Singular Value Decomposition. Towards a More Comprehensive Estimation of Anti-tumor Efficacy
    Anders Rosendal Korshoej, Axel Thielscher · 2018 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
94. Nanotechnology and Its Application in Medicine
    Mirjana D. Pavlović, John D. Mayfield, Bela Balint · 2013 · Springer eBooks
95. Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial
    Xuetao Li, Xiaoyun Shang, Jiangang Liu, Yang Zhang, Xian Jia, Huabing Li, Yihan Wang, Jianen Gao, Xu Ma, X H Zhang et al. · 2026 · Nature Communications
96. Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell Imaging
    Hoa T. Le, Michael Staelens, Davide Lazzari, Gordon K. T. Chan, Jack A. Tuszyński · 2022 · Cells
97. Cell-based therapies for glioblastoma: Promising tools against tumor heterogeneity
    Dean Nehama, Alex S. Woodell, Spencer M. Maingi, Shawn Hingtgen, Gianpietro Dotti · 2023 · Neuro-Oncology
98. Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas
    Dasun Fernando, Afsar U. Ahmed, Bryan R.G. Williams · 2024 · Frontiers in Oncology
99. Neurocognitive Function in Adult Cancer Patients
    Rebecca Anne Harrison, Jeffrey Scott Wefel · 2018 · Neurologic Clinics
100. Management of diffuse glioma
     Inés Esparragosa Vázquez, Ricardo Díez-Valle, Sonia Tejada, Jaime Gállego Pérez‐Larraya · 2018 · La Presse Médicale